Recommendations for the appropriate structure, communication, and investigation of tobacco harm reduction claims an official American thoracic society policy statement

American Journal of Respiratory and Critical Care Medicine

Volumn 198, Issue 8, 2018, Pages e90-e105

  Leone, Frank T ^a   Carlsen, Kai Håkon ^b   Chooljian, David ^c   Alexander, Laura E Crotty ^d   Detterbeck, Frank C ^e   Eakin, Michelle N ^f   Evers Casey, Sarah ^a   Farber, Harold J ^g   Folan, Patricia ^h   Kathuria, Hasmeena ⁱ   Latzka, Karen ^j   McDermott, Shane ^j   McGrath Morrow, Sharon ^f   Moazed, Farzad ^k   Munzer, Alfred ^l   Neptune, Enid ^f   Pakhale, Smita ^m   Sachs, David P L ⁿ   Samet, Jonathan ^o   Sufian, Beth ^j   Upson, Dona ^p   more..

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b OSLO UNIVERSITY HOSPITAL   (Norway)

^c LOMA LINDA UNIVERSITY   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^f JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^g TEXAS CHILDREN S HOSPITAL   (United States)

^h Northwell Health   (United States)

ⁱ BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^j American Thoracic Society   (United States)

^k UNIVERSITY OF CALIFORNIA   (United States)

^l WASHINGTON ADVENTIST HOSPITAL   (United States)

^m OTTAWA HOSPITAL RESEARCH INSTITUTE   (Canada)

ⁿ Palo Alto Center for Pulmonary Disease Prevention   (United States)

^o Food Science and Human Nutrition   (United States)

^p UNIVERSITY OF NEW MEXICO   (United States)

more..

Author keywords

Addiction; E cigarettes; Prevention; Smoking; Tobacco dependence

Indexed keywords

NICOTINE;

APPROPRIATE TECHNOLOGY; ARTICLE; CONSENSUS; HARM REDUCTION; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL ETHICS; PRIORITY JOURNAL; TOBACCO; TOBACCO DEPENDENCE; ADVERSE EVENT; CONSENSUS DEVELOPMENT; HEALTH CARE POLICY; MEDICAL INFORMATION; MEDICAL SOCIETY; SMOKING; UNITED STATES;

HARM REDUCTION; HEALTH COMMUNICATION; HEALTH POLICY; HUMANS; SMOKING; SOCIETIES, MEDICAL; TOBACCO; UNITED STATES;

EID: 85054898101     PISSN: 1073449X     EISSN: 15354970     Source Type: Journal    
DOI: 10.1164/rccm.201808-1443ST     Document Type: Article

References (109)

1. Leone FT, Carlsen K-H, Folan P, Latzka K, Munzer A, Neptune E, et al.; ATS Tobacco Action Committee; American Thoracic Society. An Official American Thoracic Society research statement: Current understanding and future research needs in tobacco control and treatment. Am J Respir Crit Care Med 2015;192:e22-e41.
2. National Center for Chronic Disease Prevention and Health Promotion (US) Office on Smoking and Health. The health consequences of smoking-50 years of progress: A report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); 2014 [accessed 2017 Dec 13]. Available from: Http://www.ncbi.nlm.nih. gov/books/NBK179276/.
3. Gerber Y, Myers V, Goldbourt U. Smoking reduction at midlife and lifetime mortality risk in men: A prospective cohort study. Am J Epidemiol 2012;175:1006-1012.
4. Jia H, Lubetkin EI. Dose-response effect of smoking status on qualityadjusted life years among US adults aged 65 years and older. J Public Health (Oxf) 2017;39:e194-e201.
5. Farone WA. Harm reduction: 25 years later. Tob Control 2002;11: 287-288.
6. Thun MJ, Burns DM. Health impact of "reduced yield" cigarettes: A critical assessment of the epidemiological evidence. Tob Control 2001;10:i4-i11.
7. U.S. Department of Health and Human Services, Public Health Service, Office on Smoking and Health. The health consequences of smoking: The changing cigarette: A report of the Surgeon General. Department of Health and Human Services publication No. (PHS) 81-50156; 1981 [accessed 2017 May 2]. Available from: Https://profiles.nlm.nih.gov/ NN/B/B/S/N/.
8. CDC's Office on Smoking and Health. Smoking and tobacco use; Surgeon General's reports: Complete report. Smoking and tobacco use. Center for Health Promotion and Education. Office on Smoking and Health; 2004 [accessed 2017 Aug 4]. Available from: Http://www. cdc.gov/tobacco/data_statistics/sgr/2004/complete_report/.
9. Kozlowski LT, Goldberg ME, Yost BA, White EL, Sweeney CT, Pillitteri JL. Smokers' misperceptions of light and ultra-light cigarettes may keep them smoking. Am J Prev Med 1998;15:9-16.
10. Davis RM, Novotny TE, Lynn WR, editors. The health consequences of smoking: nicotine addiction: A report of the Surgeon General. Center for Health Promotion and Education. Office on Smoking and Health; 1988 [accessed 2017 Aug 7]. Available from: Http://profiles.nlm.nih. gov/NN/B/B/Z/D/.
11. Kozlowski LT, Strasser AA, Giovino GA, Erickson PA, Terza JV. Applying the risk/use equilibrium: Use medicinal nicotine now for harm reduction. Tob Control 2001;10:201-203.
12. Henningfield JE, Fagerstrom KO. Swedish Match Company, Swedish snus and public health: A harm reduction experiment in progress? Tob Control 2001;10:253-257.
13. Foulds J, Ramstrom L, Burke M, Fagerström K. Effect of smokeless tobacco (snus) on smoking and public health in Sweden. Tob Control 2003;12:349-359.
14. Stratton K, Shetty P, Wallace R, Bondurant S. Clearing the smoke. National Academies Press (US); 2001 [accessed 2017 Apr 30]. Available from: Https://www.ncbi.nlm.nih.gov/pmc/articles/ PMC1747561/pdf/v010p00189.pdf.
15. Center for Addiction and Mental Health. Harm reduction [accessed 2018 Sept 25]. Available from: Https://ontario.cmha.ca/harmreduction/.
16. Kirby D. Emerging answers: Research findings on programs to reduce teen pregnancy. Washington, DC, National Campaign To Prevent Teen Pregnancy; 2001 [accessed 2017 May 3]. Available from: Https://eric.ed.gov/?id=ED456171.
17. Centers for Disease Control and Prevention (CDC). HIV, other STD, and pregnancy prevention education in public secondary schools - 45 states, 2008-2010. MMWR Morb Mortal Wkly Rep 2012;61:222-228.
18. Aspinall EJ, Nambiar D, Goldberg DJ, Hickman M, Weir A, Van Velzen E, et al. Are needle and syringe programmes associated with a reduction in HIV transmission among people who inject drugs: A systematic review and meta-analysis. Int J Epidemiol 2014;43: 235-248.
19. Abdul-Quader AS, Feelemyer J, Modi S, Stein ES, Briceno A, Semaan S, et al. Effectiveness of structural-level needle/syringe programs to reduce HCV and HIV infection among people who inject drugs: A systematic review. AIDS Behav 2013;17:2878-2892.
20. Potier C, Laprévote V, Dubois-Arber F, Cottencin O, Rolland B. Supervised injection services: what has been demonstrated? A systematic literature review. Drug Alcohol Depend 2014;145: 48-68.
21. Jones L, Hughes K, Atkinson AM, Bellis MA. Reducing harm in drinking environments: A systematic review of effective approaches. Health Place 2011;17:508-518.
22. Free C, Roberts IG, Abramsky T, Fitzgerald M, Wensley F. A systematic review of randomised controlled trials of interventions promoting effective condom use. J Epidemiol Community Health 2011;65: 100-110.
23. Zeller M, Hatsukami D; Strategic Dialogue on Tobacco Harm Reduction Group. The Strategic Dialogue on Tobacco Harm Reduction: A vision and blueprint for action in the US. Tob Control 2009;18:324-332.
24. Kozlowski LT. The truncation of moral reasoning on harm reduction by individuals and organizations. Addiction 2015;110:1070-1072.
25. Sarewitz D. Allow use of electronic cigarettes to assess risk. Nature 2014;512:349.
26. Kozlowski LT. Harm reduction, public health, and human rights: Smokers have a right to be informed of significant harm reduction options. Nicotine Tob Res 2002;4:S55-S60.
27. Kozlowski LT, Edwards BQ. "Not safe" is not enough: Smokers have a right to know more than there is no safe tobacco product. Tob Control 2005;14:ii3-ii7.
28. Douglas HE. The moral responsibilities of scientists: Tensions between autonomy and responsibility. American Philosophical Quarterly; 2012 [accessed 2017 May 3]. Available from: Http://www.academia.edu/ 987446/The_moral_responsibilities_of_scientists_tensions_between_ autonomy_and_responsibility_.
29. ICSU Committee on Freedom and Responsibility in the conduct of Science (CFRS). Advisory note: "bias in science publishing" [accessed 2018 Sept 25]. Available from: Https://council.science/cms/2017/04/ ICSU_CFRS_Advisory_Note_Bias_in_Science_Publishing.pdf.
30. Pain E. The social responsibilities of scientists. Science, AAAS; 2013 [accessed 2017 May 3]. Available from: Http://www.sciencemag. org/careers/2013/02/social-responsibilities-scientists.
31. Lindson-Hawley N, Hartmann-Boyce J, Fanshawe TR, Begh R, Farley A, Lancaster T. Interventions to reduce harm from continued tobacco use. Cochrane Database Syst Rev 2016;10:CD005231.
32. Schuman LM. Patterns of smoking behavior. NIDA Res Monogr 1977; 17:36-66.
33. RICO convictions of major tobacco companies affirmed. Washington, D.C., The Daily Washington Law Reporter; 2011 [accessed 2017 May 5]. Available from: Http://www.dwlr.com/blog/2011-05-12/ricoconvictions-major-tobacco-companies-affirmed.
34. Gendreau PL, Vitaro F. The unbearable lightness of "light" cigarettes: A comparison of smoke yields in six varieties of Canadian "light" cigarettes. Can J Public Health 2005;96:167-172.
35. Anonymous. 2016 Annual meeting of shareholders. Altria; 2016 [accessed 2017 May 3]. Available from: Http://media.corporate-ir. net/media_files/IROL/80/80855/2016ASM/Presentation.pdf.
36. Knapp DE. Brand equity. Risk Management 1999;46:71-74.
37. Ciura B. Philip Morris International's new e-cigarette could help it grow. The Motley Fool; 2014 [accessed 2017 May 3]. Available from: Https://www.fool.com/investing/general/2014/12/08/philip-morrisinternationals-new-e-cigarette-could.aspx.
38. Dewhirst T. Into the black: Marlboro brand architecture, packaging and marketing communication of relative harm. Tobacco Control 2018; 27:240-242.
39. Sparks M. Building healthy public policy: Don't believe the misdirection. Health Promot Int 2011;26:259-262.
40. Mercincavage M, Saddleson ML, Gup E, Halstead A, Mays D, Strasser AA. Reduced nicotine content cigarette advertising: How false beliefs and subjective ratings affect smoking behavior. Drug Alcohol Depend 2017;173:99-106.
41. Chapman S. The role of doctors in promoting smoking cessation. BMJ 1993;307:518-519.
42. Grüning T, Gilmore AB, McKee M. Tobacco industry influence on science and scientists in Germany. Am J Public Health 2006;96:20-32.
43. National Research Council (US) Committee on the Institutional Means for Assessment of Risks to Public Health. Risk assessment in the federal government: Managing the process. Washington, D.C.: National Academies Press (US); 1983 [accessed 2017 May 5]. Available from: Http://www.ncbi.nlm.nih.gov/books/NBK216620/.
44. National Research Council (US) Committee on Improving Risk Analysis Approaches Used by the US EPA. Science and decisions: Advancing risk assessment. Washington, D.C.: National Academies Press (US); 2009 [accessed 2017 May 5]. Available from: Http://www.ncbi.nlm. nih.gov/books/NBK214630/.
45. Scherer G, Lee PN. Smoking behaviour and compensation: A review of the literature with meta-analysis. Regul Toxicol Pharmacol 2014;70: 615-628.
46. Strasser AA, Souprountchouk V, Kaufmann A, Blazekovic S, Leone F, Benowitz NL, et al. Nicotine replacement, topography, and smoking phenotypes of e-cigarettes. Tob Regul Sci 2016;2:352-362.
47. Centers for Disease Control and Prevention (US), National Center for Chronic Disease Prevention and Health Promotion (US), Office on Smoking and Health (US). How tobacco smoke causes disease: The biology and behavioral basis for smoking-attributable disease: A report of the Surgeon General. Atlanta, GA: Centers for Disease Control and Prevention (US); 2010 [accessed 2014 Apr 14]. Available from: Http://www.ncbi.nlm.nih.gov/books/NBK53017/.
48. Benowitz NL. Nicotine addiction. N Engl J Med 2010;362:2295-2303.
49. Fiore MC, Jaén CR, Baker TB, Bailey WC, Benowitz NL, Curry SJ, et al. Treating tobacco use and dependence: 2008 update. Clinical Practice Guideline. Rockville, MD: US Department of Health and Human Services. Public Health Service; 2008.
50. Goriounova NA, Mansvelder HD. Short- and long-term consequences of nicotine exposure during adolescence for prefrontal cortex neuronal network function. Cold Spring Harb Perspect Med 2012;2: A012120.
51. Counotte DS, Spijker S, Van de Burgwal LH, Hogenboom F, Schoffelmeer ANM, De Vries TJ, et al. Long-lasting cognitive deficits resulting from adolescent nicotine exposure in rats. Neuropsychopharmacology 2009;34:299-306.
52. Leslie FM, Loughlin SE, Wang R, Perez L, Lotfipour S, Belluzzia JD. Adolescent development of forebrain stimulant responsiveness: Insights from animal studies. Ann N Y Acad Sci 2004;1021: 148-159.
53. Murthy VH. E-cigarette use among youth and young adults: A major public health concern. JAMA Pediatr 2017;171:209-210.
54. Kandel ER, Kandel DB. Shattuck lecture: A molecular basis for nicotine as a gateway drug. N Engl J Med 2014;371:932-943.
55. Leone FT, Evers-Casey S. Developing a rational approach to tobacco use treatment in pulmonary practice: A review of the biological basis of nicotine addiction. Clin Pulm Med 2012;19:53-61.
56. Robinson WS. Ecological correlations and the behavior of individuals. Int J Epidemiol 2009;38:337-341.
57. Wakefield J. Multi-level modelling, the ecologic fallacy, and hybrid study designs. Int J Epidemiol 2009;38:330-336.
58. Kannel WB. Some lessons in cardiovascular epidemiology from Framingham. Am J Cardiol 1976;37:269-282.
59. Lloyd-Jones DM, O'Donnell CJ, D'Agostino RB, Massaro J, Silbershatz H, Wilson PWF. Applicability of cholesterol-lowering primary prevention trials to a general population: The Framingham Heart Study. Arch Intern Med 2001;161:949-954.
60. Faden R, Shebaya S. Public health ethics. Stanford Encyclopedia of Philosophy. 2016 [accessed 2017 May 7]. Available from: Https://plato. stanford.edu/archives/win2016/entries/publichealth-ethics/.
61. Hammond D, Fong GT, Zanna MP, Thrasher JF, Borland R. Tobacco denormalization and industry beliefs among smokers from four countries. Am J Prev Med 2006;31:225-232.
62. Hamby DM. A review of techniques for parameter sensitivity analysis of environmental models. Environ Monit Assess 1994;32: 135-154.
63. Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, et al. Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: Meta-epidemiological study. BMJ 2008;336:601-605.
64. Chen J, Millar WJ. Age of smoking initiation: Implications for quitting. Health Rep 1998;9:39-46.
65. Savitz DA, Meyer RE, Tanzer JM, Mirvish SS, Lewin F. Public health implications of smokeless tobacco use as a harm reduction strategy. Am J Public Health 2006;96:1934-1939.
66. Anderson HR, Cook DG. Passive smoking and sudden infant death syndrome: Review of the epidemiological evidence. Thorax 1997;52: 1003-1009.
67. Elliot J, Vullermin P, Robinson P. Maternal cigarette smoking is associated with increased inner airway wall thickness in children who die from sudden infant death syndrome. Am J Respir Crit Care Med 1998;158:802-806.
68. Haland G, Carlsen KCL, Sandvik L, Devulapalli CS, Munthe-Kaas MC, Pettersen M, et al.; ORAACLE. Reduced lung function at birth and the risk of asthma at 10 years of age. N Engl J Med 2006;355: 1682-1689.
69. Lødrup Carlsen KC, Mowinckel P, Hovland V, Haland G, Riiser A, Carlsen K-H. Lung function trajectories from birth through puberty reflect asthma phenotypes with allergic comorbidity. J Allergy Clin Immunol 2014;134:917-923, e7.
70. Li YF, Langholz B, Salam MT, Gilliland FD. Maternal and grandmaternal smoking patterns are associated with early childhood asthma. Chest 2005;127:1232-1241.
71. Magnus MC, Haberg SE, Karlstad Ø, Nafstad P, London SJ, Nystad W. Grandmother's smoking when pregnant with the mother and asthma in the grandchild: The Norwegian Mother and Child Cohort Study. Thorax 2015;70:237-243.
72. Baba S, Wikström A-K, Stephansson O, Cnattingius S. Influence of smoking and snuff cessation on risk of preterm birth. Eur J Epidemiol 2012;27:297-304.
73. Baba S, Wikström A-K, Stephansson O, Cnattingius S. Changes in snuff and smoking habits in Swedish pregnant women and risk for small for gestational age births. BJOG 2013;120: 456-462.
74. Baba S, Wikström A-K, Stephansson O, Cnattingius S. Influence of snuff and smoking habits in early pregnancy on risks for stillbirth and early neonatal mortality. Nicotine Tob Res 2014;16: 78-83.
75. Wongtrakool C, Roser-Page S, Rivera HN, Roman J. Nicotine alters lung branching morphogenesis through the a7 nicotinic acetylcholine receptor. Am J Physiol Lung Cell Mol Physiol 2007;293:L611-L618.
76. Wongtrakool C, Wang N, Hyde DM, Roman J, Spindel ER. Prenatal nicotine exposure alters lung function and airway geometry through a7 nicotinic receptors. Am J Respir Cell Mol Biol 2012;46:695-702.
77. DubéCE, Lapane KL. Lay abstracts and summaries: writing advice for scientists. J Cancer Educ 2014;29:577-579.
78. Harris B. The intractable cigarette 'filter problem'. Tob Control 2011;20: I10-i16.
79. Pauly JL, Mepani AB, Lesses JD, Cummings KM, Streck RJ. Cigarettes with defective filters marketed for 40 years: what Philip Morris never told smokers. Tob Control 2002;11:I51-I61.
80. O'Connor RJ, Bansal-Travers M, Cummings KM, Hammond D, Thrasher JF, Tworek C. Filter presence and tipping paper color influence consumer perceptions of cigarettes. BMC Public Health 2015;15:1279.
81. Woloshin S, Schwartz LM, Casella SL, Kennedy AT, Larson RJ. Press releases by academic medical centers: not so academic? Ann Intern Med 2009;150:613-618.
82. Sumner P, Vivian-Griffiths S, Boivin J, Williams A, Venetis CA, Davies A, et al. The association between exaggeration in health related science news and academic press releases: Retrospective observational study. BMJ 2014;349:g7015.
83. Etter J-F, Kozlowski LT, Perneger TV. What smokers believe about light and ultralight cigarettes. Prev Med 2003;36:92-98.
84. O'Connor RJ, McNeill A, Borland R, Hammond D, King B, Boudreau C, et al. Smokers' beliefs about the relative safety of other tobacco products: Findings from the ITC collaboration. Nicotine Tob Res 2007;9:1033-1042.
85. Krishnan-Sarin S, Morean M, Kong G, Bold KW, Camenga DR, Cavallo DA, et al. E-cigarettes and "dripping" among high-school youth. Pediatrics 2017;139:e20163224.
86. Talih S, Balhas Z, Salman R, Karaoghlanian N, Shihadeh A. "Direct dripping": A high-temperature, high-formaldehyde emission electronic cigarette use method. Nicotine Tob Res 2016;18:453-459.
87. Bartschat S, Mercer-Chalmers-Bender K, Beike J, Rothschild MA, J ubner M. Not only smoking is deadly: Fatal ingestion of e-juice - A case report. Int J Legal Med 2015;129:481-486.
88. Emanuel EJ, Wendler D, Grady C. What makes clinical research ethical? JAMA 2000;283:2701-2711.
89. National Institutes of Health. HTA 101: V. Economic analysis methods [accessed 2018 Sept 25]. Available from: Https://www.nlm.nih. gov/nichsr/hta101/ta10107.html.
90. Asfar T, Ebbert JO, Klesges RC, Relyea GE. Do smoking reduction interventions promote cessation in smokers not ready to quit? Addict Behav 2011;36:764-768.
91. Mann H, Djulbegovic B. Comparator bias: why comparisons must address genuine uncertainties. JLL Bulletin [accessed 2017 May 10]. Available from: Http://www.jameslindlibrary.org/articles/comparatorbias-why-comparisons-must-address-genuine-uncertainties/.
92. Emanuel EJ, Grady CC, Crouch RA, Lie RK, Miller FG, Wendler DD, editors. The Oxford Textbook of Clinical Research Ethics. Reprint edition. Oxford: Oxford University Press; 2011.
93. Cheetham A, Allen NB, Yücel M, Lubman DI. The role of affective dysregulation in drug addiction. Clin Psychol Rev 2010;30: 621-634.
94. Macklin R. Bioethics, vulnerability, and protection. Bioethics. 2003 [accessed 2017 Aug 20]. Available from: Http://www.readcube.com/ articles/10.1111/1467-8519.00362.
95. Lewin T. US investigating Johns Hopkins study of lead paint hazard. The New York Times. 2001 Aug 24 [accessed 2017 May 10]. Available from: Http://www.nytimes.com/2001/08/24/us/us-investigatingjohns-hopkins-study-of-lead-paint-hazard.html.
96. Cameron J. WHO. Valuing water, valuing livelihoods. Chapter 11. IWA Publishing; 2011 [accessed 2017 May 6]. Available from: Https://www. scribd.com/document/272337704/Valuing-Water-Valuing-Livehoods.
97. U.S. Food and Drug Administration. Rules, regulations & guidance. Family smoking prevention and tobacco control act: An overview [accessed 2018 Sept 25]. Available from: Https://www.fda.gov/ tobaccoproducts/labeling/rulesregulationsguidance/ucm246129. htm.
98. Farber HJ, Groner J, Walley S, Nelson K; Section on Tobacco Control. Protecting children from tobacco, nicotine, and tobacco smoke. Pediatrics 2015;136:e1439-e1467.
99. Wills TA, Sargent JD, Gibbons FX, Pagano I, Schweitzer R. E-cigarette use is differentially related to smoking onset among lower risk adolescents. Tob Control 2016;26:534-539.
100. Vallerand RJ, Toward A. Hierarchical model of intrinsic and extrinsic motivation. Adv Exp Soc Psychol 1997;29:271-360.
101. Brady JV, Lukas SE, editors. Testing drugs for physical dependence potential and abuse liability. Department of Health and Human Services; 1984 [accessed 2018 Sept 25]. Available from: Https:// archives.drugabuse.gov/sites/default/files/monograph52.pdf.
102. Dackis C, O'Brien C. Neurobiology of addiction: Treatment and public policy ramifications. Nat Neurosci 2005;8:1431-1436.
103. Leone FT, Evers-Casey S, Graden S, Schnoll R. Behavioral economic insights into physician tobacco treatment decision-making. Ann Am Thorac Soc 2015;12:364-369.
104. Leone FT, Evers-Casey S, Graden S, Schnoll R, Mallya G. Academic detailing interventions improve tobacco use treatment among physicians working in underserved communities. Ann Am Thorac Soc 2015;12:854-858.
105. E-cigarettes. The BMJ [accessed 2018 Sept 25]. Available from: Http://www.bmj.com/campaign/e-cigarettes.
106. Leone FT, Douglas IS. The emergence of e-cigarettes: A triumph of wishful thinking over science. Ann Am Thorac Soc 2014;11:216-219.
107. Guyatt GH, Oxman AD, Kunz R, Vist GE, Falck-Ytter Y, Schünemann HJ; GRADE Working Group. What is "quality of evidence" and why is it important to clinicians? BMJ 2008;336:995-998.
108. Schünemann HJ, Oxman AD, Brozek J, Glasziou P, Jaeschke R, Vist GE, et al.; GRADE Working Group. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies. BMJ 2008;336:1106-1110.
109. World Health Organization. Public health surveillance [accessed 2018 Sept 25]. Available from: Http://www.who.int/immunization/ monitoring_surveillance/burden/vpd/en/.